Diamyd Logo
This website is only intended for investors

Fighting diabetes

Diamyd Medical is a diabetes company active in the field of pharmaceutical development. The Company is headquartered in Stockholm, Sweden and shares are listed on Nasdaq Stockholm First North (ticker: DMYD B).
World Diabetes Day Logo
Diamyd® is the Antigen-Based Therapy that is at the forefront of development and can be used on children due to its favorable safety profile.
Diabetes is associated with serious complications due to elevated and fluctuating blood sugar levels, causing substantial suffering and extensive costs for society.
Diamyd Medical has made a flying start to the autumn and the company is a hive of activity. Among all these activities, we will manufacture fresh GAD protein at our long-term partner Protein Sciences...
Diamyd® is a GAD-based therapy under development for the treatment and prevention of autoimmune diabetes such as type 1 diabetes and LADA. Treatment with Diamyd® aims to intervene in the autoimmune...
rss icon
    
pdf icon
15 oktober 2014, 08:30
Bokslutskommuniké 13/14